Klaria Pharma
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.
Klaria receives additional subscription commitments and extends the subscription period in the Company's rights issue
REG
Below is an updated timetable for the Rights Offering. As a result of the extended subscription period, the period for trading in unit rights is also extended to November 3. All other terms and conditions remain as before.
| Event | Date |
| Trading in unit rights | October 14-November 3, 2026 |
| Subscription period | October 14-November 6, 2026 |
| Trading in paid subscribed units (BTU) | October 14-November 24, 2026 |
| Expected announcement of the preliminary outcome | November 9, 2026 |
| Expected announcement of the final outcome | November 10, 2026 |
More information about the Rights Offering can be found on the Company's website, www.klaria.com, and on the issue page www.ii.se/klaria-rights-issue-of-units-2026/